As a result, SIRT1 expression is inhibited by miR-326 to inhibit HIF1α and elevate VEGFA due to decreased chemoresistance, thus inhibiting the progression of NSCLC [250, 251]. The gene discussed is SIRT1; the disease is non-small cell lung carcinoma.